Summary
GlobalData's clinical trial report, “Rabies Global Clinical Trials Review, H1, 2016" provides an overview of Rabies clinical trials scenario. This report provides top line data relating to the clinical trials on Rabies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Novartis AG
Sanofi
Johnson & Johnson
Serum Institute of India Limited
Molecular Targeting Technologies, Inc.
Cadila Pharmaceuticals Limited
Novavax, Inc.
Kaketsuken K.K.
CureVac GmbH
Bharat Biotech International Limited
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Rabies to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Rabies to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Rabies Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 77
List of Tables
Rabies Therapeutics, Global, Clinical Trials by Region, 2016* 6
Rabies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Rabies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Rabies Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Rabies Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Rabies Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Rabies Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Proportion of Rabies to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13
Rabies Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Rabies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Rabies to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16
Rabies Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Rabies Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Rabies Therapeutics, Global, Clinical Trials by Phase, 2016* 19
Rabies Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
Rabies Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Rabies Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Rabies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Rabies Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
Rabies Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Rabies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Rabies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
List of Figures
Rabies Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Rabies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Rabies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Rabies Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Rabies Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Rabies Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Proportion of Rabies to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13
Rabies Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Rabies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Rabies to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16
Rabies Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Rabies Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Rabies Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
Rabies Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
Rabies Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Rabies Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Rabies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Rabies Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
Rabies Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Rabies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Rabies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 75
